Literature DB >> 17202998

The pitfalls in the development of biologic therapy.

Ravinder N Maini, Marc Feldmann.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17202998     DOI： 10.1038/ncprheum0373

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN： 1745-8382


× No keyword cloud information.
  4 in total

1.  Chronic disease: when in doubt, consider accrual into a randomized controlled trial (RCT).

Authors:  J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2008-08       Impact factor: 4.335

2.  1974-2014: Reflections on the evolution of clinical pharmacology in the past 40 years and a message to our readers.

Authors:  James M Ritter
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

Review 3.  How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targets.

Authors:  Virginia Pascual; Florence Allantaz; Pinakeen Patel; A Karolina Palucka; Damien Chaussabel; Jacques Banchereau
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

Review 4.  Blood gene expression profiling in pediatric systemic lupus erythematosus and systemic juvenile idiopathic arthritis: from bench to bedside.

Authors:  Mileka Gilbert; Marilynn Punaro
Journal:  Pediatr Rheumatol Online J       Date:  2014-05-08       Impact factor: 3.054
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.